Analysis for iShares J. Morgan USD Emerging Markets Bond ETF
Analysis summary
iShares J. Morgan USD Emerging Markets Bond ETF (EMB) currently has a total score of 43 points, placing it in the neutral range. The score is made up of Performance (21), Stability (79) and Trend (44). The profile is clearly uneven: Stability stands out while Performance lags.
Performance scores 21 points (weak). Least weak metric: 1Y return at 7.7 %. Main drag: 10Y return at -6.7 %. This points to a sharper upswing more recently.
Stability scores 79 points (strong). Key strength: volatility (365d, annualized) at 6.6 %. Main drag: CAGR/drawdown ratio at -0.02. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 44 points (neutral). Most supportive metric: trend strength at 0.59. Weaker signal: Price is about 1.5 % above SMA100.
Overall, the picture is mixed: Stability does the heavy lifting while Performance holds the score back. On a metric level, volatility (365d, annualized) stands out, while 10Y return lags.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does iShares J. Morgan USD Emerging Markets Bond ETF fit best in FoxScore?
- iShares J. Morgan USD Emerging Markets Bond ETF fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
- How meaningful is the available history for iShares J. Morgan USD Emerging Markets Bond ETF?
- iShares J. Morgan USD Emerging Markets Bond ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.